15 minute interview with Dr Jan Turner, who explains how organoids and organs on chips are enabling new knowledge of human biology and disease. These miniature models of human systems provide human-relevant insights and can be personalised to individual diseases, allowing studies that have never been possible before. These infinitely adaptable tools overcome the insurmountable limitations of animal models, ushering in a future of better, more efficient drug development and safer medicines for patients.
Listen here:
cytivalifesciences.com/en/gb/podcast
Thanks to Cytiva and Dr Jan Turner, our much-missed former Director.
World Patient Safety Day is grounded in the most fundamental principle of medicine – first do no harm “Medication Safety” is the theme for World Patient Safety Day 2022. Safer Medicines Trust is a patient safety charity whose mission is to improve the safety of medicines, so we very much support calls for “Medication Without Harm”. The World […]
The crisis of Alzheimer’s disease research: it’s time to embrace a new approach to help patientsThe problem Alzheimer’s disease (AD) is a leading cause of death in the UK and along with other dementias, is responsible for almost 11% of all deaths in England.1 More than 209,000 new cases are diagnosed each year across the UK.2 It remains a leading cause of death and disability worldwide3, affecting nearly 50 million […]
